Orbimed Advisors elevated stake in X4 Prescribed drugs, Inc. By Investing.com
© Reuters. Orbimed Advisors elevated stake in X4 Prescribed drugs, Inc.
On the twenty third of March, Orbimed Advisors purchased 750 thousand X4 Prescribed drugs, Inc. (NASDAQ:) shares for $7 million at a mean value of $9.31 per share.
Shares of X4 Prescribed drugs, Inc. are down -1.61% for the reason that transaction.
Orbimed Advisors’s holding in X4 Prescribed drugs, Inc. elevated to about 1.8 million shares with the acquisition.
Orbimed Advisors first purchased X4 Prescribed drugs, Inc. inventory within the first quarter of 2019.
Different buyers who additionally added to their X4 Prescribed drugs, Inc. shares embrace Citigroup (NYSE:) and Squarepoint Ops.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury on account of reliance on the data together with knowledge, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding varieties attainable.
McDonald’s (MCD) Q3 2021 earnings
People wear protective face masks outside McDonald’s in Union Square as the city continues Phase 4 of re-opening following restrictions…
Deutsche Bank optimistic on revenues after profit tops forecasts By Reuters
© Reuters. FILE PHOTO: The headquarters of Germany’s Deutsche Bank are pictured in Frankfurt, Germany, September 21, 2020. REUTERS/Ralph Orlowski…